Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 741

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 741
---
 ​ | ​                  | ​ |        — | ​ | ​ | ​ | ​                                 | ​ |   96 | ​ | ​ | ​ | ​                        | ​ |      96 | ​ | ​ |
| Balance at September 30, 2024                        | ​      | ​ | ​            | ​ | 4,570,553 | ​ | ​      | ​ | ​ | $ | 5 | ​ | ​ | ​ | ​                        | $ | 748,660 | ​ | ​ | ​ | ​                  | $ | -747,933 | ​ | ​ | ​ | ​                                 | $ |  -25 | ​ | ​ | ​ | ​                        | $ |     707 | ​ | ​ |

See Notes to Condensed Consolidated Financial Statements. F-4

TABLE OF CONTENTS

CARA THERAPEUTICS, INC. CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (continued)
(amounts in thousands except share and per share data)
(unaudited)

| ​                                                                         
 ​                                                                         | ​      
 Shares | ​ | Common Stock |   |         ​ | ​ | Amount |   |   |   | ​ |   | ​ | ​ | AdditionalPaid-InCapital |   |         |   | ​ | ​ | AccumulatedDeficit |   |          |   | ​ | ​ | AccumulatedOtherComprehensiveLoss |   |        |   | ​ | ​ | TotalStockholders’Equity |   |         |   | ​ |
|:--------------------------------------------------------------------------|:-------|:--|:-------------|:--|----------:|:--|:-------|:--|:--|:--|--:|:--|:--|:--|:-------------------------|:--|--------:|:--|:--|:--|:-------------------|:--|---------:|:--|:--|:--|:----------------------------------|:--|-------:|:--|:--|:--|:-------------------------|:--|--------:|:--|:--|
| Balance at December 31, 2022                                              | ​      | ​ | ​            | ​ | 4,483,112 | ​ | ​      | ​ | ​ | $ | 4 | ​ | ​ | ​ | ​                        | $ | 726,679 | ​ | ​ | ​ | ​                  | $ | -566,232